Martina Amnitzbøll Eriksen – Research output — The Capital Region of Denmark's Research Portal

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 Journal article

1 results

2022
A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study
Eriksen, M., Pfeiffer, P., Rohrberg, K. S., Yde, C. W., Petersen, L. N., Poulsen, L. Ø. & Qvortrup, C., 16 Dec 2022, In: BMC Cancer. 22, 1, p. 1-6 6 p., 1321.
Research output: Contribution to journal › Journal article › Research › peer-review